Vertex completes rolling BLA submission for povetacicept
Source: SeekingAlpha
2026-03-31 17:50:06 ET
More on Vertex Pharmaceuticals
- Vertex Pharmaceuticals Incorporated (VRTX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
- Vertex Pharmaceuticals Incorporated (VRTX) Presents at Leerink Global Healthcare Conference 2026 Transcript
- Is A Vertex Buyout Of Crispr Therapeutics Inevitable? Here's My Take
- Vertex Pharmaceuticals climbs on positive interim data from IgAN phase 3 trial
- Key deals this week: KORE, TopBuild, Equinix, PayPal and more
Read the full article on Seeking Alpha
For further details see:
Vertex completes rolling BLA submission for povetacicept
Vertex Pharmaceuticals Incorporated
NASDAQ: VRTX
VRTX Trading
0.83% G/L:
$442.47 Last:
20,295 Volume:
$442.35 Open:
VRTX Latest News
April 14, 2026 04:05:00 am
Trump's Team Says Don't Worry About Rising Inflation. Here Are 3 Stocks to Buy If They're Wrong.VRTX Stock Data
$118,425,801,558
253,211,393
0.21%
875
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
